Evidence map›Paper›PMID 27184339›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2016

Investigating the Impact of a Genome-Wide Supported Bipolar Risk Variant of MAD1L1 on the Human Reward System.

Sarah Trost, Esther K Diekhof, Holger Mohr, Henning Vieker, Bernd Krämer, Claudia Wolf, Maria Keil, Peter Dechent, Elisabeth B Binder, Oliver Gruber

Registry-linked trialOpen access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03810703 (Hypomania, Amphetamine, and Preferences for Sweets), which is not on this map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03810703 phase1completednot on this mapstarted 2017, after this paper: background citation

Hypomania, Amphetamine, and Preferences for Sweets

TypeinterventionalSponsorUniversity of ChicagoRan2017 to 2018Enrolled93ConditionsBipolar II DisorderArmsPlacebo oral capsule, d-amphetamine 10 mg oral capsule, d-amphetamine 20 mg oral capsule
3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Sarah TrostDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Esther K DiekhofDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Holger MohrDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Henning ViekerDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Bernd KrämerDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Claudia WolfDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Maria KeilDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
Peter DechentDepartment of Cognitive Neurology, Georg August University, Goettingen, Germany.
Elisabeth B BinderDepartment of Translational Psychiatry, Max Planck Institute of Psychiatry, Munich, Germany.
Oliver GruberDepartment of Psychiatry and Psychotherapy, Center for Translational Research in Systems Neuroscience and Clinical Psychiatry, Georg August University Goettingen, Goettingen, Germany.
University of Göttingen · DEMax Planck Institute of Psychiatry · DENational Institute on Aging · USTU Dresden · DEUniversity Hospital Heidelberg · DEUniversity Medical Center Hamburg-Eppendorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent genome-wide association studies have identified MAD1L1 (mitotic arrest deficient-like 1) as a susceptibility gene for bipolar disorder and schizophrenia. The minor allele of the single-nucleotide polymorphism (SNP) rs11764590 in MAD1L1 was associated with bipolar disorder. Both diseases, bipolar disorder and schizophrenia, are linked to functional alterations in the reward system. We aimed at investigating possible effects of the MAD1L1 rs11764590 risk allele on reward systems functioning in healthy adults. A large homogenous sample of 224 young (aged 18-31 years) participants was genotyped and underwent functional magnetic resonance imaging (fMRI). All participants performed the 'Desire-Reason Dilemma' paradigm investigating the neural correlates that underlie reward processing and active reward dismissal in favor of a long-term goal. We found significant hypoactivations of the ventral tegmental area (VTA), the bilateral striatum and bilateral frontal and parietal cortices in response to conditioned reward stimuli in the risk allele carriers compared with major allele carriers. In the dilemma situation, functional connectivity between prefrontal brain regions and the ventral striatum was significantly diminished in the risk allele carriers. Healthy risk allele carriers showed a significant deficit of their bottom-up response to conditioned reward stimuli in the bilateral VTA and striatum. Furthermore, functional connectivity between the ventral striatum and prefrontal areas exerting top-down control on the mesolimbic reward system was reduced in this group. Similar alterations in reward processing and disturbances of prefrontal control mechanisms on mesolimbic brain circuits have also been reported in bipolar disorder and schizophrenia. Together, these findings suggest the existence of an intermediate phenotype associated with MAD1L1.

Indexed as

Brain MappingRewardAdolescentAdultBipolar DisorderBrainCell Cycle ProteinsConditioning, OperantFemaleGenome-Wide Association StudyGenotypeHumansImage Processing, Computer-AssistedMagnetic Resonance ImagingMaleNeural PathwaysCell Cycle ProteinsMAD1L1 protein, humanNuclear ProteinsOxygen

Identifiers

PMID27184339
PMCPMC5026735
OpenAlexW2398791114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.